University of Minnesota research is a key part of the Twin Cities's growing industry for microbiome-based medical treatments.
An interactive mobile app developed at the University of Minnesota helps users learn about geographical points of interest as they travel.
Biotech incubator University Enterprise Laboratories, founded in 2003 as a partnership between the U of M and the city of St. Paul, is planning an 18,000 square foot expansion.
A recent article on the potential for collaborations between universities and companies highlighted the University of Minnesota's role in bolstering the region's medical devices industry.
A mobile survey tool developed at the U of M will provide city planners with the data needed to make better transportation decisions.
The University of Minnesota is one of many contributors to Minnesota's strong economic performance in recent years.
Following a clinical study led in part by a U of M neurologist, Boston Scientific has received FDA approval for its Vercise Deep Brain Stimulation system.
Workshops at the U of M aim to encourage nurses to develop new medtech ideas into marketable technologies.
U of M biotech startup Miromatrix was among the MinneInno's of 15 Minnesota startups that raised funding in fall 2017.
U of M scientists played a crucial role in helping a first-of-its-kind treatment for several rare genetic diseases reach clinical trials.
Sign up for the UMN Research newsletter >